Alkermes plc. Increase (Decrease) in Inventories
Alkermes plc. (ALKS) reported Increase (Decrease) in Inventories of -$1.01 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-07-28
- Alkermes plc. increase (decrease) in inventories for the quarter ending 2026-06-30 was -$7.44M, a 189.74% decline year-over-year.
- Alkermes plc. increase (decrease) in inventories for the quarter ending 2026-03-31 was $6.43M, a 267.05% increase year-over-year.
- Alkermes plc. increase (decrease) in inventories for the quarter ending 2025-12-31 was $4.86M.
- Alkermes plc. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$845.00K.
- Alkermes plc. increase (decrease) in inventories for fiscal 2025 was $14.06M.
- Alkermes plc. increase (decrease) in inventories for fiscal 2024 was -$3.09M, a 213.97% decline from fiscal 2023.
- Alkermes plc. increase (decrease) in inventories for fiscal 2023 was $2.71M, a 91.26% decline from fiscal 2022.
- Alkermes plc. increase (decrease) in inventories for fiscal 2022 was $31.02M, a 25.24% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$7.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | -$1.01M 10-Q · filed 2026-07-28 | $3.85M derived: sum of 3 quarters · filed 2026-07-28 | $3.00M derived: sum of 4 quarters · filed 2026-07-28 |
| 2026-03-31 | $6.43M 10-Q · filed 2026-05-05 | $11.29M derived: sum of 2 quarters · filed 2026-05-05 | $10.45M derived: sum of 3 quarters · filed 2026-05-05 | $18.74M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-12-31 | $4.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $4.02M derived: sum of 2 quarters · filed 2026-02-25 | $12.31M derived: sum of 3 quarters · filed 2026-07-28 | $14.06M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$845.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $7.45M derived: sum of 2 quarters · filed 2026-07-28 | $9.20M 10-Q · filed 2025-10-28 | $56.00K derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-06-30 | $8.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | $10.04M 10-Q · filed 2026-07-28 | $901.00K derived: sum of 3 quarters · filed 2026-07-28 | -$2.59M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-03-31 | $1.75M 10-Q · filed 2026-05-05 | -$7.39M derived: sum of 2 quarters · filed 2026-05-05 | -$10.88M derived: sum of 3 quarters · filed 2026-05-05 | -$13.98M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$9.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$12.63M derived: sum of 2 quarters · filed 2026-02-25 | -$15.73M derived: sum of 3 quarters · filed 2026-02-25 | -$3.09M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$3.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$6.59M derived: sum of 2 quarters · filed 2025-10-28 | $6.05M 10-Q · filed 2025-10-28 | -$1.10M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$3.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $9.54M 10-Q · filed 2025-07-29 | $2.38M derived: sum of 3 quarters · filed 2026-02-25 | $5.37M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $12.64M 10-Q · filed 2025-05-01 | $5.49M derived: sum of 2 quarters · filed 2026-02-25 | $8.47M derived: sum of 3 quarters · filed 2026-02-25 | $13.32M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$7.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$4.17M derived: sum of 2 quarters · filed 2026-02-25 | $683.00K derived: sum of 3 quarters · filed 2026-02-25 | $2.71M 10-K · filed 2026-02-25 |
| 2023-09-30 | $2.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | $7.84M derived: sum of 2 quarters · filed 2024-10-24 | $9.87M 10-Q · filed 2024-10-24 | $25.24M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | $4.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-24 | $6.88M 10-Q · filed 2024-07-24 | $22.25M derived: sum of 3 quarters · filed 2025-02-12 | $33.33M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | $2.03M 10-Q · filed 2024-05-01 | $17.40M derived: sum of 2 quarters · filed 2025-02-12 | $28.48M derived: sum of 3 quarters · filed 2025-02-12 | $28.77M derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | $15.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $26.45M derived: sum of 2 quarters · filed 2025-02-12 | $26.74M derived: sum of 3 quarters · filed 2025-02-12 | $31.02M 10-K · filed 2025-02-12 |
| 2022-09-30 | $11.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | $11.36M derived: sum of 2 quarters · filed 2023-10-25 | $15.65M 10-Q · filed 2023-10-25 | $27.04M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $284.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26 | $4.57M 10-Q · filed 2023-07-26 | $15.96M derived: sum of 3 quarters · filed 2024-02-21 | $18.11M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $4.29M 10-Q · filed 2023-04-26 | $15.68M derived: sum of 2 quarters · filed 2024-02-21 | $17.82M derived: sum of 3 quarters · filed 2024-02-21 | $20.40M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $11.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $13.54M derived: sum of 2 quarters · filed 2024-02-21 | $16.12M derived: sum of 3 quarters · filed 2024-02-21 | $24.77M 10-K · filed 2024-02-21 |
| 2021-09-30 | $2.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $4.72M derived: sum of 2 quarters · filed 2022-11-02 | $13.38M 10-Q · filed 2022-11-02 | $15.56M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $2.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $11.23M 10-Q · filed 2022-07-27 | $13.42M derived: sum of 3 quarters · filed 2023-02-16 | $20.38M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $8.65M 10-Q · filed 2022-04-27 | $10.84M derived: sum of 2 quarters · filed 2023-02-16 | $17.80M derived: sum of 3 quarters · filed 2023-02-16 | $24.74M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $9.15M derived: sum of 2 quarters · filed 2023-02-16 | $16.09M derived: sum of 3 quarters · filed 2023-02-16 | $22.93M 10-K · filed 2023-02-16 |
| 2020-09-30 | $6.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | $13.91M derived: sum of 2 quarters · filed 2021-10-27 | $20.75M 10-Q · filed 2021-10-27 | $23.50M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $6.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $13.78M 10-Q · filed 2021-07-28 | $16.54M derived: sum of 3 quarters · filed 2022-02-16 | $22.93M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $6.84M 10-Q · filed 2021-04-28 | $9.60M derived: sum of 2 quarters · filed 2022-02-16 | $15.99M derived: sum of 3 quarters · filed 2022-02-16 | $18.22M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $9.15M derived: sum of 2 quarters · filed 2022-02-16 | $11.38M derived: sum of 3 quarters · filed 2022-02-16 | $13.08M 10-K · filed 2022-02-16 |
| 2019-09-30 | $6.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $8.62M derived: sum of 2 quarters · filed 2020-10-29 | $10.32M 10-Q · filed 2020-10-29 | $10.39M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | $2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $3.93M 10-Q · filed 2020-07-29 | $4.00M derived: sum of 3 quarters · filed 2021-02-11 | $4.51M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | $1.70M 10-Q · filed 2020-04-29 | $1.77M derived: sum of 2 quarters · filed 2021-02-11 | $2.28M derived: sum of 3 quarters · filed 2021-02-11 | $3.93M derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $583.00K derived: sum of 2 quarters · filed 2021-02-11 | $2.23M derived: sum of 3 quarters · filed 2021-02-11 | $2.67M 10-K · filed 2021-02-11 |
| 2018-09-30 | $514.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-23 | $2.17M derived: sum of 2 quarters · filed 2019-10-23 | $2.60M 10-Q · filed 2019-10-23 | $10.94M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $2.08M 10-Q · filed 2019-07-25 | $10.43M derived: sum of 3 quarters · filed 2020-02-13 | $17.69M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $431.00K 10-Q · filed 2019-04-25 | $8.78M derived: sum of 2 quarters · filed 2020-02-13 | $16.04M derived: sum of 3 quarters · filed 2020-02-13 | $29.89M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $8.35M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $15.61M derived: sum of 2 quarters · filed 2020-02-13 | $29.46M derived: sum of 3 quarters · filed 2020-02-13 | $30.19M 10-K · filed 2020-02-13 |
| 2017-09-30 | $7.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | $21.11M derived: sum of 2 quarters · filed 2018-10-23 | $21.84M 10-Q · filed 2018-10-23 | $31.07M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | $13.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $14.59M 10-Q · filed 2018-07-26 | $23.81M derived: sum of 3 quarters · filed 2019-02-15 | $27.72M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | $733.00K 10-Q · filed 2018-04-26 | $9.96M derived: sum of 2 quarters · filed 2019-02-15 | $13.87M derived: sum of 3 quarters · filed 2019-02-15 | $19.13M derived: sum of 4 quarters · filed 2019-02-15 |
| 2016-12-31 | $9.22M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $13.14M derived: sum of 2 quarters · filed 2019-02-15 | $18.40M derived: sum of 3 quarters · filed 2019-02-15 | $26.38M 10-K · filed 2019-02-15 |
| 2016-09-30 | $3.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $9.17M derived: sum of 2 quarters · filed 2017-10-26 | $17.16M 10-Q · filed 2017-10-26 | |
| 2016-06-30 | $5.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $13.24M 10-Q · filed 2017-07-27 | ||
| 2016-03-31 | $7.98M 10-Q · filed 2017-04-27 | |||
| 2015-12-31 | -$3.69M 10-K · filed 2018-02-16 | |||
| 2014-12-31 | $4.21M 10-K · filed 2017-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |